Trial Profile
Epidemiological research on safety and efficacy of Yokukansan in the long-term treatment of behavioral and psychological symptoms of dementia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 May 2012
Price :
$35
*
At a glance
- Drugs TJ 54 (Primary)
- Indications Dementia
- Focus Adverse reactions; Pharmacodynamics
- 17 May 2012 New trial record